Part of the book series:Methods in Molecular Biology ((MIMB,volume 315))
Abstract
Mast cells are fascinating, multifunctional, tissue-dwelling cells that have been traditionally associated with the allergic response. However, recent studies suggest these cells may be capable of regulating inflammation, host defense, and innate immunity. The purpose of this review is to present salient aspects of mast cell biology in the context of mast cell function in physiology and disease. After their development from bone marrow-derived progenitor cells that are primed with stem cell factor, mast cells continue their maturation and differentiation in peripheral tissue, developing into two well-described subsets of cells, MCT and MCTC cells. These cells can be distinguished on the basis of their tissue location, dependence on T lymphocytes, and their granule contents. Mast cells can undergo activation by antigens/allergens (acting via the high-affinity receptor for immunoglobulin E, also referred to as FcεRI), superoxides, complement proteins, neuropeptides, and lipoproteins. After activation, mast cells express histamine, leukotrienes, and prostanoids, as well as proteases, and many cytokines and chemokines. These mediators may be pivotal to the genesis of an inflammatory response. By virtue of their location and mediator expression, mast cells may play an active role in many diseases, such as allergy, parasitic diseases, atherosclerosis, malignancy, asthma, pulmonary fibrosis, and arthritis. Recent data also suggest that mast cells play a vital role in host defense against pathogens by elaboration of tumor necrosis factor alpha. Mast cells also express the Toll-like receptor, which may further accentuate their role in the immune-inflammatory response. This chapter summarizes the many well-known and novel functional aspects of human mast cell biology and emphasizes their unique role in the inflammatory response.
This is a preview of subscription content,log in via an institution to check access.
Similar content being viewed by others
References
Bloom, G. D. (1984) A short history of the mast cell.Acta Otolaryngol. Suppl.414, 87–92.
Metcalfe, D. D., Baram, D., and Mekori, Y. A. (1997) Mast cells.Physiol. Rev77, 1033–1079.
Church, M. K. and Levi-Schaffer, F. (1997) The human mast cell.J. Allergy Clin. Immunol.99, 155–160.
Kelley, J. L., Chi, D. S., Abou-Auda, W., Smith, J. K., and Krishnaswamy, G. (2000) The molecular role of mast cells in atherosclerotic cardiovascular disease.Mol. Med. Today6, 304–308.
Valent, P. (1995) Cytokines involved in growth and differentiation of human basophils and mast cells.Exp. Dermatol.4, 255–259.
Valent, P., Sillaber, C., and Bettelheim, P. (1991) The growth and differentiation of mast cells.Prog. Growth Factor Res.3, 27–41.
Galli, S. J., Tsai, M., Wershil, B. K., Tam, S. Y., and Costa, J. J. (1995) Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor.Int. Arch. Allergy Immunol.107, 51–53.
Kirshenbaum, A. S., Goff, J. P., Semere, T., Foster, B., Scott, L. M., and Metcalfe, D. D. (1999) Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13).Blood94, 2333–2342.
Kirshenbaum, A. S., Kessler, S. W., Goff, J. P., and Metcalfe, D. D. (1991) Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells.J. Immunol.146, 1410–1415.
Nilsson, G., Butterfield, J. H., Nilsson, K., and Siegbahn, A. (1994) Stem cell factor is a chemotactic factor for human mast cells.J. Immunol.153, 3717–3723.
Vliagoftis, H., Worobec, A. S., and Metcalfe, D. D. (1997) The protooncogene c-kit and c-kit ligand in human disease.J. Allergy Clin. Immunol.100, 435–440.
Nagata, H., Worobec, A. S., Semere, T., and Metcalfe, D. D. (1998) Elevated expression of the proto-oncogene c-kit in patients with mastocytosis.Leukemia12, 175–181.
Worobec, A. S., Semere, T., Nagata, H., and Metcalfe, D. D. (1998) Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis.Cancer83, 2120–2129.
Mekori, Y. A., Oh, C. K., and Metcalfe, D. D. (1995) The role of c-Kit and its ligand, stem cell factor, in mast cell apoptosis.Int. Arch. Allergy Immunol.107, 136–138.
Mekori, Y. A., Gilfillan, A. M., Akin, C., Hartmann, K., and Metcalfe, D. D. (2001) Human mast cell apoptosis is regulated through Bcl-2 and Bcl-XL.J. Clin. Immunol.21, 171–174.
Quackenbush, E. J., Wershil, B. K., Aguirre, V., and Gutierrez-Ramos, J. C. (1998) Eotaxin modulates myelopoiesis and mast cell development from embryonic hematopoietic progenitors.Blood92, 1887–1897.
Kirshenbaum, A. S., Goff, J. P., Albert, J. P., Kessler, S. W., and Metcalfe, D. D. (1994) Fibroblasts determine the fate of Fc epsilon RI+ cell populations in vitro by selectively supporting the viability of mast cells while internalizing and degrading basophils.Int. Arch. Allergy Immunol.105, 374–380.
Atkins, F. M., Friedman, M. M., Subba Rao, P. V., and Metcalfe, D. D. (1985) Interactions between mast cells, fibroblasts and connective tissue components.Int. Arch. Allergy Appl. Immunol.77, 96–102.
Schwartz, L. B. (1998) The mast cell, inTextbook of Rheumatology (Kelley, W. N., Harris, E. D., Ruddy, S., and Sledge, C. B., eds.), W.B. Saunders Company, Philadelphia, pp. 161–175.
Schwartz, L. B., Irani, A. M., Roller, K., Castells, M. C., and Schechter, N. M. (1987) Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells.J. Immunol.138, 2611–2615.
Kraemer, R. (1987) [Mechanisms of allergic reactions and potential therapeutic approach in childhood bronchial asthma] Mechanismen der allergischen Reaktion und mogliche therapeutische Ansatze beim kindlichen Asthma bronchiale.Schweiz. Rundsch. Med. Prax.76, 581–585.
Fung-Leung, W. P., Sousa-Hitzler, J., Ishaque, A., et al. (1996) Transgenic mice expressing the human high-affinity immunoglobulin (Ig) E receptor alpha chain respond to human IgE in mast cell degranulation and in allergic reactions.J. Exp. Med.183, 49–56.
Nadler, M. J., Matthews, S. A., Turner, H., and Kinet, J. P. (2000) Signal transduction by the high-affinity immunoglobulin E receptor Fc epsilon RI: coupling form to function.Adv. Immunol.76, 325–355.
Turner, H. and Kinet, J. P. (1999) Signalling through the high-affinity IgE receptor Fc epsilonRI.Nature402, B24–B30.
Daeron, M., Malbec, O., Latour, S., Espinosa, E., Pina, P., and Fridman, W. H. (1995) Regulation of tyrosine-containing activation motif-dependent cell signalling by Fc gamma RII.Immunol. Lett.44, 119–123.
Hibbs, M. L. and Dunn, A. R. (1997) Lyn, a src-like tyrosine kinase.Int. J. Biochem. Cell Biol.29, 397–400.
Suzuki, H., Takei, M., Yanagida, M., Nakahata, T., Kawakami, T., and Fukamachi, H. (1997) Early and late events in Fc epsilon RI signal transduction in human cultured mast cells.J. Immunol.159, 5881–5888.
Marone, G., Casolaro, V., Patella, V., Florio, G., and Triggiani, M. (1997) Molecular and cellular biology of mast cells and basophils.Int. Arch. Allergy Immunol.114, 207–217.
Schulman, E. S. (1993) The role of mast cells in inflammatory responses in the lung.Crit. Rev. Immunol.13, 35–70.
Schulman, E. S., Post, T. J., Henson, P. M., and Giclas, P. C. (1988) Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release.J. Clin. Invest.81, 918–923.
Prodeus, A. P., Zhou, X., Maurer, M., Galli, S. J., and Carroll, M. C. (1997) Impaired mast cell-dependent natural immunity in complement C3-deficient mice.Nature390, 172–175.
Abraham, S. N. and Malaviya, R. (1997) Mast cells in infection and immunity.Infect. Immun.65, 3501–3508.
Malaviya, R. and Abraham, S. N. (1998) Clinical implications of mast cell-bacteria interaction.J. Mol. Med.76, 617–623.
Galli, S. J. and Wershil, B. K. (1996) The two faces of the mast cell.Nature381, 21–22.
Galli, S. J. (1993) New concepts about the mast cell.N. Engl. J. Med.328, 257–265.
Ackermann, L., Pelkonen, J., and Harvima, I. T. (1998) Staphylococcal enterotoxin B inhibits the production of interleukin-4 in a human mast-cell line HMC-1.Immunology94, 247–252.
McCloskey, M. A. (1988) Cholera toxin potentiates IgE-coupled inositol phospholipid hydrolysis and mediator secretion by RBL-2H3 cells.Proc. Natl. Acad. Sci. USA85, 7260–7264.
Galli, S. J., Maurer, M., and Lantz, C. S. (1999) Mast cells as sentinels of innate immunity.Curr. Opin. Immunol.11, 53–59.
Silber, G., Proud, D., Warner, J., et al. (1988) In vivo release of inflammatory mediators by hyperosmolar solutions.Am. Rev. Respir. Dis.137, 606–612.
Fitzgerald, S. M., Lee, S. A., Hall, H. K., Chi, D. S., and Krishnaswamy, G. (2004) Human lung fibroblasts express interleukin-6 in response to signaling after mast cell contact.Am. J. Respir. Cell Mol. Biol.30, 585–593.
Chi, D. S., Fitzgerald, S. M., Pitts, S., et al. (2004) MAPK-dependent regulation of IL-1-and beta-adrenoreceptor-induced inflammatory cytokine production from mast cells: implications for the stress response.BMC Immunol.5, 22.
Krishnaswamy, G., Hall, K., Youngberg, G., et al. (2002) Regulation of eosinophil-active cytokine production from human cord blood-derived mast cells.J. Interferon Cytokine Res.22, 379–388.
Lee, S. A., Fitzgerald, S. M., Huang, S. K., et al. (2004) Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta.Am. J. Respir. Cell Mol. Biol.31, 283–291.
Abraham, S. N., Thankavel, K., and Malaviya, R. (1997) Mast cells as modulators of host defense in the lung.Front. Biosci.2, d78–d87.
Plaut, M., Pierce, J. H., Watson, C. J., Hanley-Hyde, J., Nordan, R. P., and Paul, W. E. (1989) Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores.Nature339, 64–67.
Bradding, P. and Holgate, S. T. (1996) The mast cell as a source of cytokines in asthma.Ann. N.Y. Acad. Sci.796, 272–281.
Bradding, P. (1996) Human mast cell cytokines.Clin. Exp. Allergy.26, 13–19.
Malaviya, R., Ikeda, T., Ross, E., and Abraham, S. N. (1996) Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha.Nature381, 77–80.
Walsh, L. J., Trinchieri, G., Waldorf, H. A., Whitaker, D., and Murphy, G. F. (1991) Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1.Proc. Natl. Acad. Sci. USA88, 4220–4224.
Bradding, P., Mediwake, R., Feather, I. H., et al. (1995) TNF alpha is localized to nasal mucosal mast cells and is released in acute allergic rhinitis.Clin. Exp. Allergy25, 406–415.
Anderson, W. H., Davidson, T. M., and Broide, D. H. (1996) Mast cell TNF mRNA expression in nasal mucosa demonstrated byin situ hybridization: a comparison of mast cell detection methods.J. Immunol. Methods189, 145–155.
Ackerman, V., Marini, M., Vittori, E., Bellini, A., Vassali, G., and Mattoli, S. (1994) Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients. Relationship to atopic status, symptoms, and level of airway hyperresponsiveness.Chest105, 687–696.
Buckley, M. G., Williams, C. M., Thompson, J., et al. (1995) IL-4 enhances IL-3 and IL-8 gene expression in a human leukemic mast cell line.Immunology84, 410–415.
Krishnaswamy, G., Lakshman, T., Miller, A. R., et al. (1997) Multifunctional cytokine expression by human mast cells: regulation by T cell membrane contact and glucocorticoids.J. Interferon. Cytokine. Res.17, 167–176.
Bradding, P., Roberts, J. A., Britten, K. M., et al. (1994) Interleukin-4,-5, and-6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines.Am. J. Respir. Cell Mol. Biol.10, 471–480.
Bradding, P., Feather, I. H., Wilson, S., et al. (1993) Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation.J. Immunol.151, 3853–3865.
Ying, S., Humbert, M., Barkans, J., et al. (1997) Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics.J. Immunol.158, 3539–3544.
Ando, M., Miyazaki, E., Fukami, T., Kumamoto, T., and Tsuda, T. (1999) Interleukin-4-producing cells in idiopathic pulmonary fibrosis: an immunohistochemical study.Respirology4, 383–391.
Barata, L. T., Ying, S., Meng, Q., et al. (1998) IL-4-and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects.J. Allergy Clin. Immunol.101, 222–230.
Okayama, Y., Petit-Frere, C., Kassel, O., et al. (1995) IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells.J. Immunol.155, 1796–1808.
Lippert, U., Kruger-Krasagakes, S., Moller, A., Kiessling, U., and Czarnetzki, B. M. (1995) Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines.Exp. Dermatol.4, 272–276.
Bradding, P., Feather, I. H., Wilson, S., Holgate, S. T., and Howarth, P. H. (1995) Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid.Am. J. Respir. Crit. Care Med.151, 1900–1906.
Bradding, P., Okayama, Y., Howarth, P. H., Church, M. K., and Holgate, S. T. (1995) Heterogeneity of human mast cells based on cytokine content.J. Immunol.155, 297–307.
Kruger-Krasagakes, S., Grutzkau, A., Krasagakis, K., Hoffmann, S., and Henz, B. M. (1999) Adhesion of human mast cells to extracellular matrix provides a co-stimulatory signal for cytokine production.Immunology98, 253–257.
Grutzkau, A., Kruger-Krasagakes, S., Kogel, H., Moller, A., Lippert, U., and Henz, B. M. (1997) Detection of intracellular interleukin-8 in human mast cells: flow cytometry as a guide for immunoelectron microscopy.J. Histochem. Cytochem.45, 935–945.
Hultner, L., Kolsch, S., Stassen, M., et al. (2000) In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9.J. Immunol.164, 5556–5563.
Ishizuka, T., Okayama, Y., Kobayashi, H., and Mori, M. (1999) Interleukin-10 is localized to and released by human lung mast cells.Clin. Exp. Allergy29, 1424–1432.
Burd, P. R., Thompson, W. C., Max, E. E., and Mills, F. C. (1995) Activated mast cells produce interleukin 13.J. Exp. Med.181, 1373–1380.
Toru, H., Pawankar, R., Ra, C., Yata, J., and Nakahata, T. (1998) Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells.J. Allergy Clin. Immunol.102, 491–502.
Kanbe, N., Kurosawa, M., Yamashita, T., Kurimoto, F., Yanagihara, Y., and Miyachi, Y. (1999) Cord-blood-derived human cultured mast cells produce interleukin 13 in the presence of stem cell factor.Int. Arch. Allergy Immunol.119, 138–142.
Rumsaeng, V., Cruikshank, W. W., Foster, B., et al. (1997) Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16.J. Immunol.159, 2904–2910.
Yano, K., Yamaguchi, M., de Mora, F., et al. (1997) Production of macrophage inflammatory protein-1alpha by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability.Lab. Invest.77, 185–193.
Selvan, R. S., Butterfield, J. H., and Krangel, M. S. (1994) Expression of multiple chemokine genes by a human mast cell leukemia.J. Biol. Chem.269, 13,893–13,898.
Trautmann, A., Toksoy, A., Engelhardt, E., Brocker, E. B., and Gillitzer, R. (2000) Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo.J. Pathol.190, 100–106.
Baghestanian, M., Hofbauer, R., Kiener, H. P., et al. (1997) The c-kit ligand stem cell factor and anti-IgE promote expression of monocyte chemoattractant protein-1 in human lung mast cells.Blood90, 4438–4449.
Yamada, T., Sawatsubashi, M., Yakushiji, H., et al. (1998) Localization of vascular endothelial growth factor in synovial membrane mast cells: examination with “multi-labelling subtraction immunostainin”.Virchows Arch.433, 567–570
Nilsson, G., Forsberg-Nilsson, K., Xiang, Z., Hallbook, F., Nilsson, K., and Metcalfe, D. D. (1997) Human mast cells express functional TrkA and are a source of nerve growth factor.Eur. J. Immunol.27, 2295–2301.
De Paulis, A., Minopoli, G., Arbustini, E., et al. (1999) Stem cell factor is localized in, released from, and cleaved by human mast cells.J. Immunol.163, 2799–2808.
Zhang, S., Anderson, D. F., Bradding, P., et al. (1998) Human mast cells express stem cell factor.J. Pathol.186, 59–66.
Krishnaswamy, G., Mukkamala, R., Yerra, L., and Smith, J. K. (1999) Molecular therapies for asthma.Fed. Pract.2, 16–26.
Byrd, R. P., Krishnaswamy, G., and Roy, T. M. (2000) Difficult-to-manage asthma. How to pinpoint the exacerbating factors.Postgrad. Med.108, 37–51.
Gauchat, J. F., Henchoz, S., Mazzei, G., et al. (1993) Induction of human IgE synthesis in B cells by mast cells and basophils.Nature365, 340–343.
Stadler, B. M. and Gauchat, D. (1987) [Current concepts in immunoregulation and its significance for allergies] Concepts nouveaux de l’immuno-regulation et leur signification pour l’allergie.Rev. Med. Suisse Romande107, 289–293.
Paul,W. E. and Seder, R. A. (1994) Lymphocyte responses and cytokines.Cell76, 241–251.
Karpus, W. J., Lukacs, N. W., Kennedy, K. J., Smith, W. S., Hurst, S. D., and Barrett, T. A. (1997) Differential CC chemokine-induced enhancement of T helper cell cytokine production.J. Immunol.158, 4129–4136.
Szczeklik, A. (2000) Atopy and sudden cardiac death.Lancet355, 2254.
Szczeklik, A., Sladek, K., Szczerba, A., and Dropinski, J. (1988) Serum immunoglobulin E response to myocardial infarction.Circulation77, 1245–1249.
Kauhanen, P., Kovanen, P. T., Reunala, T., and Lassila, R. (1998) Effects of skin mast cells on bleeding time and coagulation activation at the site of platelet plug formation.Thromb. Haemost.79, 843–847.
Jeziorska, M., McCollum, C., and Woolley, D. E. (1997) Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries.J. Pathol.182, 115–122.
Kovanen, P. T., Kaartinen, M., and Paavonen, T. (1995) Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction.Circulation92, 1084–1088.
Reilly, C. F., Schechter, N. B., and Travis, J. (1985) Inactivation of bradykinin and kallidin by cathepsin G and mast cell chymase.Biochem. Biophys. Res. Commun.127, 443–449.
Uehara, Y., Urata, H., Sasaguri, M., et al. (2000) Increased chymase activity in internal thoracic artery of patients with hypercholesterolemia.Hypertension35, 55–60.
Paananen, K. and Kovanen, P. T. (1994) Proteolysis and fusion of low density lipoprotein particles independently strengthen their binding to exocytosed mast cell granules.J. Biol. Chem.269, 2023–2031.
Lindstedt, L., Lee, M., Castro, G. R., Fruchart, J. C., and Kovanen, P. T. (1996) Chymase in exocytosed rat mast cell granules effectively proteolyses apolipoprotein AI-containing lipoproteins, so reducing the cholesterol effluxinducing ability of serum and aortic intimal fluid.J. Clin. Invest.97, 2174–2182.
Sillaber, C., Baghestanian, M., Bevec, D., et al. (1999) The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis.J. Immunol.162, 1032–1041.
Cho, S. H., Tam, S. W., Demissie-Sanders, S., Filler, S. A., and Oh, C. K. (2000) Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma.J. Immunol.165, 3154–3161.
Schwartz, L. B., Bradford, T. R., Littman, B. H., and Wintroub, B. U. (1985) The fibrinogenolytic activity of purified tryptase from human lung mast cells.J. Immunol.135, 2762–2767.
Henz, B. M., Maurer, M., Lippert, U., Worm, M., and Babina, M. (2001) Mast cells as initiators of immunity and host defense.Exp. Dermatol.10, 1–10.
Mekori, Y. A. and Metcalfe, D. D. (1999) Mast cell-T cell interactions.J. Allergy Clin. Immunol.104, 517–523.
Arock, M., Ross, E., Lai-Kuen, R., Averlant, G., Gao, Z., and Abraham, S. N. (1998) Phagocytic and tumor necrosis factor alpha response of human mast cells following exposure to gram-negative and gram-positive bacteria.Infect. Immun.66, 6030–6034.
Levi-Schaffer, F. and Rubinchik, E. (1995) Mast cell role in fibrotic diseases.Isr. J. Med. Sci.31, 450–453.
Chlap, Z., Jedynak, U., and Sladek, K. (1998) [Mast cell: its significance in bronchoalveolar lavage fluid cytologic diagnosis of bronchial asthma and interstitial lung disease] Komorka tuczna: znaczenie w diagnostyce cytologicznej plynu oskrzelowo-pecherzykowego w astmie oskrzelowej i chorobach srodmiazszowych pluc.Pneumonol. Alergol. Pol.66, 321–329.
Hunt, L. W., Colby, T. V., Weiler, D. A., Sur, S., and Butterfield, J. H. (1992) Immunofluorescent staining for mast cells in idiopathic pulmonary fibrosis: quantification and evidence for extracellular release of mast cell tryptase.Mayo Clin. Proc.67, 941–948.
Ehara, T. and Shigematsu, H. (1998) Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis.Kidney Int.54, 1675–1683.
Inoue, Y., King, T. E., Jr., Tinkle, S. S., Dockstader, K., and Newman, L. S. (1996) Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders.Am. J. Pathol.149, 2037–2054.
Chanez, P., Lacoste, J. Y., Guillot, B., et al. (1993) Mast cells’ contribution to the fibrosing alveolitis of the scleroderma lung.Am. Rev. Respir. Dis.147, 1497–1502.
Lee, Y. S. and Vijayasingam, S. (1995) Mast cells and myofibroblasts in keloid: a light microscopic, immunohistochemical and ultrastructural study.Ann. Acad. Med. Singapore24, 902–905.
Pesci, A., Bertorelli, G., Gabrielli, M., and Olivieri, D. (1993) Mast cells in fibrotic lung disorders.Chest103, 989–996.
Jordana, M. (1993) Mast cells and fibrosis—who’s on first?Am. J. Respir. Cell Mol. Biol.8, 7–8.
Yamashita, Y., Nakagomi, K., Takeda, T., Hasegawa, S., and Mitsui, Y. (1992) Effect of heparin on pulmonary fibroblasts and vascular cells.Thorax47, 634–639.
Jordana, M., Befus, A. D., Newhouse, M. T., Bienenstock, J., and Gauldie, J. (1988) Effect of histamine on proliferation of normal human adult lung fibroblasts.Thorax43, 552–558.
Levi-Schaffer, F., Kelav-Appelbaum, R., and Rubinchik, E. (1995) Human foreskin mast cell viability and functional activity is maintained ex vivo by coculture with fibroblasts.Cell Immunol.162, 211–216.
Heard, B. E., Dewar, A., and Corrin, B. (1992) Apposition of fibroblasts to mast cells and lymphocytes in normal human lung and in cryptogenic fibrosing alveolitis. Ultrastructure and cell perimeter measurements.J. Pathol.166, 303–310.
Adawi, A., Zhang, Y., Baggs, R., et al. (1998) Blockade of CD40-CD40 ligand interactions protects against radiation-induced pulmonary inflammation and fibrosis.Clin. Immunol. Immunopathol.89, 222–230.
Williams, C. M. and Galli, S. J. (2000) The diverse potential effector and immunoregulatory roles of mast cells in allergic disease.J. Allergy Clin. Immunol.105, 847–859.
Worobec, A. S., Akin, C., Scott, L. M., and Metcalfe, D. D. (1998) Cytogenetic abnormalities and their lack of relationship to the Asp816Val c-kit mutation in the pathogenesis of mastocytosis.J. Allergy Clin. Immunol.102, 523–524.
Nagata, H., Okada, T., Worobec, A. S., Semere, T., and Metcalfe, D. D. (1997) c-kit mutation in a population of patients with mastocytosis.Int. Arch. Allergy Immunol.113, 184–186.
Akin, C., Kirshenbaum, A. S., Semere, T., Worobec, A. S., Scott, L. M., and Metcalfe, D. D. (2000) Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis.Exp. Hematol.28, 140–147.
Metcalfe, D. D. and Akin, C. (2001) Mastocytosis: molecular mechanisms and clinical disease heterogeneity.Leuk. Res.25, 577–582.
Hartmann, K. and Henz, B. M. (2001) Mastocytosis: recent advances in defining the disease.Br. J. Dermatol.144, 682–695.
Soter, N. A. (2000) Mastocytosis and the skin.Hematol. Oncol. Clin. North Am.14, 537–55, vi.
Horny, H. P., Ruck, P., Krober, S., and Kaiserling, E. (1997) Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis.Histol. Histopathol.12, 1081–1089.
Pullarkat, V. A., Pullarkat, S. T., Calverley, D. C., and Brynes, R. K. (2000) Mast cell disease associated with acute myeloid leukemia: detection of a new ckit mutation Asp816His.Am. J. Hematol.65, 307–309.
Lehmann, T., Beyeler, C., Lammle, B., et al. (1996) Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-2B.Br. J. Rheumatol.35, 898–900.
Parker, R. I. (2000) Hematologic aspects of systemic mastocytosis.Hematol.Oncol. Clin. North Am.14, 557–568.
Schwartz, L. B., Sakai, K., Bradford, T. R., et al. (1995) The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis.J. Clin. Invest.96, 2702–2710.
Dabbous, M. K., Woolley, D. E., Haney, L., Carter, L. M., and Nicolson, G. L. (1986) Host-mediated effectors of tumor invasion: role of mast cells in matrix degradation.Clin. Exp. Metastasis4, 141–152.
Duncan, L. M., Richards, L. A., and Mihm, M. C., Jr. (1998) Increased mast cell density in invasive melanoma.J. Cutan. Pathol.25, 11–15.
Le Querrec, A., Duval, D., and Tobelem, G. (1993) Tumour angiogenesis.Baillieres Clin. Haematol.6, 711–730.
Marone, G., Florio, G., Triggiani, M., Petraroli, A., and De Paulis, A. (2000) Mechanisms of IgE elevation in HIV-1 infection.Crit. Rev. Immunol.20, 477–496.
Kolodgie, F. D., Virmani, R., Cornhill, J. F., Herderick, E. E., and Smialek, J. (1991) Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis.J. Am. Coll. Cardiol.17, 1553–1560.
Kelley, J., Chi, D. S., Henry, J., Stone, W. L., Smith, J. K., and Krishnaswamy, G. (2000) HIV-and cocaine-induced cardiovascular disease: pathogenesis and clinical implications.Cardiovasc. Rev. Rep.XXI, 365–370.
Buckley, M. G., Walters, C., Wong, W. M., et al. (1997) Mast cell activation in arthritis: detection of alpha-and beta-tryptase, histamine and eosinophil cationic protein in synovial fluid.Clin. Sci. (Colch.)93, 363–370.
Mican, J. M. and Metcalfe, D. D. (1990) Arthritis and mast cell activation.J. Allergy Clin. Immunol.86, 677–683.
Renoux, M., Hilliquin, P., Galoppin, L., Florentin, I., and Menkes, C. J. (1996) Release of mast cell mediators and nitrites into knee joint fluid in osteoarthritis—comparison with articular chondrocalcinosis and rheumatoid arthritis.Osteoarthritis Cartilage4, 175–179.
Renoux, M., Hilliquin, P., Galoppin, L., Florentin, J., and Menkes, C. J. (1995) Cellular activation products in osteoarthritis synovial fluid.Int. J. Clin. Pharmacol. Res.15, 135–138.
Woolley, D. E. and Tetlow, L. C. (2000) Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.Arthritis Res.2, 65–74.
He, S., Gaca, M. D., and Walls, A. F. (2001) The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors.Eur. J. Pharmacol.412, 223–229.
Bridges, A. J., Malone, D. G., Jicinsky, J., et al. (1991) Human synovial mast cell involvement in rheumatoid arthritis and osteoarthritis. Relationship to disease type, clinical activity, and antirheumatic therapy.Arthritis Rheum.34, 1116–1124.
Olsson, N., Ulfgren, A. K., and Nilsson, G. (2001) Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients.Ann. Rheum. Dis.60, 187–193.
Yamada, T., Sawatsubashi, M., Yakushiji, H., et al. (1998) Localization of vascular endothelial growth factor in synovial membrane mast cells: examination with “multi-labelling subtraction immunostaining.”Virchows Arch.433, 567–570
Skopouli, F. N., Li, L., Boumba, D., et al. (1998) Association of mast cells with fibrosis and fatty infiltration in the minor salivary glands of patients with Sjogren’s syndrome.Clin. Exp. Rheumatol.16, 63–65.
Enestrom, S., Bengtsson, A., and Frodin, T. (1997) Dermal IgG deposits and increase of mast cells in patients with fibromyalgia—relevant findings or epiphenomena?Scand. J. Rheumatol.26, 308–313.
Acknowledgments
The authors acknowledge the excellent secretarial assistance of Ms. Dolores Moore. This chapter was funded by NIH grants AI-43310 and HL-63070, the Rondal Cole Foundation and the Chair of Excellence in Medicine (State of Tennessee grant 20233), Cardiovascular Research Institute, AMGEN, Inc., and the Research Development Committee, East Tennessee State University.
Author information
Authors and Affiliations
Division of Allergy and Immunology, Department of Internal Medicine, James H. Quillen VAMC and the Quillen College of Medicine, East Tennessee State University, Johnson City, TN
Guha Krishnaswamy
Department of Internal Medicine, Quillen College of Medicine, East Tennessee State University, Johnson City, TN
Omar Ajitawi & David S. Chi
- Guha Krishnaswamy
You can also search for this author inPubMed Google Scholar
- Omar Ajitawi
You can also search for this author inPubMed Google Scholar
- David S. Chi
You can also search for this author inPubMed Google Scholar
Editor information
Editors and Affiliations
Quillen College of Medicine, James H. Quillen Veterans Affairs Medical Center, East Tennessee State University, Johnson City, TN
Guha Krishnaswamy & David S. Chi &
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Krishnaswamy, G., Ajitawi, O., Chi, D.S. (2006). The Human Mast Cell. In: Krishnaswamy, G., Chi, D.S. (eds) Mast Cells. Methods in Molecular Biology, vol 315. Humana Press. https://doi.org/10.1385/1-59259-967-2:013
Download citation
Publisher Name:Humana Press
Print ISBN:978-1-58829-374-9
Online ISBN:978-1-59259-967-7
eBook Packages:Springer Protocols